Comments on: Multidrug resistance-associated protein (MRP) expression is correlated with expression of aberrant p53 protein in colorectal cancer, Fukushima Y, Oshika Y, Tokunaga T, et al., Eur J Cancer 1999, 35, 935-938. Mutant p53 and high expression of MRP are associated in acute myeloblastic leukaemia

By Turzanski J.   Zhu Y.-M.   Pallis M.J.   Russell N.H.  

European Journal of Cancer, Vol. 36, Iss. 2, 2000-01 ,pp. : 270-271

Elsevier

Access to resources Recommend Favorite

Expression of MDR1/P-glycoprotein, the multidrug resistance protein MRP, and the lung-resistance protein LRP in multiple myeloma

By Schwarzenbach Heidi  

Medical Oncology, Vol. 19, Iss. 2, 2002-06 ,pp. : 87-104

Humana Press, Inc

Access to resources Recommend Favorite

Expression levels of multidrug resistance-associated protein 4 (MRP4) in human leukemia and lymphoma cell lines, and the inhibitory effects of the MRP-specific inhibitor MK-571 on methotrexate distribution in rats

By        

Experimental and Therapeutic Medicine, Vol. 4, Iss. 3, 2012-01 ,pp. : 524-532

Spandidos Publications

Access to resources Recommend Favorite

Expression and significance of glucose transporter-1, P-glycoprotein, multidrug resistance-associated protein and glutathione S-transferase-π in laryngeal carcinoma

By  

Oncology Letters, Vol. 9, Iss. 2, 2015-01 ,pp. : 806-810

Spandidos Publications

Access to resources Recommend Favorite

Lapatinib sensitizes quiescent MDA-MB-231 breast cancer cells to doxorubicin by inhibiting the expression of multidrug resistance-associated protein-1

By        

Oncology Reports, Vol. 34, Iss. 2, 2015-01 ,pp. : 884-890

Spandidos Publications

Access to resources Recommend Favorite